Traditional Chinese medicine improves synaptic plasticity in Alzheimer's disease: A review of experimental studies
10.1097/st9.0000000000000106
- Author:
Shan HE
1
;
Xinyu YANG
2
;
Junhe SHI
2
;
Wenxuan CHEN
2
;
Hui PEI
2
;
Hao LI
3
;
Lina MA
2
Author Information
1. Institute of Geriatrics, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China; Geriatrics Department, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China
2. Institute of Geriatrics, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China
3. Geriatrics Department, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China
- Publication Type:Journal Article
- Keywords:
Alzheimer's disease;
Synaptic plasticity;
Synaptoprotein;
Traditional Chinese medicine
- From:
Science of Traditional Chinese Medicine
2026;4(1):1-9
- CountryChina
- Language:English
-
Abstract:
Abnormal synaptic plasticity is an early pathological feature of Alzheimer disease (AD). Synaptic damage and dysfunction initiate neuronal degeneration and death, ultimately leading to cognitive impairment. Traditional Chinese medicine (TCM) can effectively ameliorate cognitive dysfunction through multitarget regulation of synaptic plasticity. This review summarizes the mechanisms by which TCM, including active components, single herbs, and classical formulas, modulates synaptic plasticity, offering new insights for future research and clinical applications. Relevant experimental studies published between 2020 and 2024 were retrieved from major databases, including China National Knowledge Infrastructure, the National Science and Technology Library, Wanfang Data, Elsevier, ScienceDirect, PubMed, SpringerLink, and Web of Science. Network pharmacology and bioinformatics approaches were used to predict the therapeutic effects and mechanisms of TCM on AD-related synaptic plasticity. In total, 15 TCM single herbs and 11 TCM formulas were identified as enhancing AD-related synaptic plasticity. Additionally, 15 active ingredients targeting synaptic plasticity in AD were retrieved from TCM databases over the past decade. This review provides novel perspectives and strategic directions for future AD research and therapeutic development.
